Martínez-Baz Iván, Casado Itziar, Miqueleiz Ana, Navascués Ana, Pozo Francisco, Trobajo-Sanmartín Camino, Albéniz Esther, Elía Fernando, Burgui Cristina, Fernández-Huerta Miguel, Ezpeleta Carmen, Castilla Jesús
Instituto de Salud Pública de Navarra, Pamplona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
Euro Surveill. 2022 Jun;27(26). doi: 10.2807/1560-7917.ES.2022.27.26.2200488.
Compared with individuals unvaccinated in the current and three previous influenza seasons, in 2021/22, influenza vaccine effectiveness at primary care level was 37% (95% CI: 16 to 52) for current season vaccination, regardless of previous doses, and 35% (95% CI: -3 to 45) for only previous seasons vaccination. Against influenza A(H3N2), estimates were 39% (95% CI: 16 to 55) and 24% (95% CI: -8 to 47) suggesting moderate effectiveness of current season vaccination and possible remaining effect of prior vaccinations.
与当前及之前三个流感季节未接种疫苗的个体相比,在2021/22年度,无论之前是否接种过疫苗,初级保健层面的流感疫苗有效性在当季接种时为37%(95%置信区间:16%至52%),仅在前几个季节接种时为35%(95%置信区间:-3%至45%)。针对甲型(H3N2)流感,估计值分别为39%(95%置信区间:16%至55%)和24%(95%置信区间:-8%至47%),表明当季接种具有中等有效性,且之前接种可能仍有效果。